Comparative characterization of flavivirus production in two cell lines: Human hepatoma-derived Huh7.5.1-8 and African green monkey kidney-derived Vero.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
21
11
2019
accepted:
10
04
2020
entrez:
25
4
2020
pubmed:
25
4
2020
medline:
24
7
2020
Statut:
epublish
Résumé
The Flaviviridae is a family of enveloped viruses with a positive-sense single-stranded RNA genome. It contains many viruses that threaten human health, such as Japanese encephalitis virus (JEV) and yellow fever virus (YFV) of the genus Flavivirus as well as hepatitis C virus of the genus Hepacivirus. Cell culture systems highly permissive for the Flaviviridae viruses are very useful for their isolation, propagation, and diagnosis, an understanding of their biology, and the development of vaccines and antiviral agents. Previously, we isolated a human hepatoma HuH-7-derived cell clone, Huh7.5.1-8, which is highly permissive to hepatitis C virus infection. Here, we have characterized flavivirus infection in the Huh7.5.1-8 cell line by comparing with that in the African green monkey kidney-derived Vero cell line, which is permissive for a wide spectrum of viruses. Upon infection with JEV, Huh7.5.1-8 cells produced a higher amount of virus particles early in infection and were more susceptible to virus-induced cell death than Vero cells. Similar outcomes were obtained when the cells were infected with another flavivirus, YFV (17D-204 strain). Quantification of cellular and extracellular viral RNA revealed that high JEV production in Huh7.5.1-8 cells can be attributed to rapid viral replication kinetics and efficient virus release early in infection. In a plaque assay, Huh7.5.1-8 cells developed JEV plaques more rapidly than Vero cells. Although this was not the case with YFV plaques, Huh7.5.1-8 cells developed higher numbers of YFV plaques than Vero cells. Sequence analysis of cDNA encoding an antiviral RNA helicase, RIG-I, showed that Huh7.5.1-8 cells expressed not only a full-length RIG-I mRNA with a known dominant-negative missense mutation but also variants without the mutation. However, the latter mRNAs lacked exon 5/6-12, indicating functional loss of RIG-I in the cells. These characteristics of the Huh7.5.1-8 cell line are helpful for flavivirus detection, titration, and propagation.
Identifiants
pubmed: 32330205
doi: 10.1371/journal.pone.0232274
pii: PONE-D-19-32355
pmc: PMC7182267
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0232274Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Biol Chem. 2006 Oct 6;281(40):30279-88
pubmed: 16895911
Vaccine. 2015 Nov 4;33(44):5905-12
pubmed: 26187258
Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):582-7
pubmed: 17190814
Virology. 2015 May;479-480:110-21
pubmed: 25749629
Virus Res. 2018 Jan 15;244:64-70
pubmed: 29113824
J Virol. 2005 Jul;79(13):8388-99
pubmed: 15956583
Expert Rev Vaccines. 2015;14(9):1167-79
pubmed: 26162529
J Gen Virol. 2005 Aug;86(Pt 8):2209-2220
pubmed: 16033968
J Immunol Res. 2014;2014:787023
pubmed: 25101306
Curr Opin Immunol. 2015 Feb;32:48-53
pubmed: 25594890
Vector Borne Zoonotic Dis. 2005 Summer;5(2):137-45
pubmed: 16011430
J Gen Virol. 2013 Aug;94(Pt 8):1749-1760
pubmed: 23620378
J Virol. 2017 Mar 29;91(8):
pubmed: 28179530
Viral Immunol. 2008 Jun;21(2):123-32
pubmed: 18476771
J Virol. 2002 Dec;76(24):13001-14
pubmed: 12438626
Jpn J Infect Dis. 2015;68(2):81-8
pubmed: 25420655
J Clin Microbiol. 2007 Feb;45(2):584-9
pubmed: 17108075
Proc Natl Acad Sci U S A. 1988 Jul;85(14):5259-63
pubmed: 3134658
Proc Soc Exp Biol Med. 1969 Nov;132(2):670-8
pubmed: 4982209
Bull World Health Organ. 2011 Oct 1;89(10):766-74, 774A-774E
pubmed: 22084515
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16743-8
pubmed: 18948594
PLoS One. 2011;6(6):e21761
pubmed: 21738791
J Exp Med. 1937 May 31;65(6):767-86
pubmed: 19870633
Cancer Res. 1982 Sep;42(9):3858-63
pubmed: 6286115
DNA Res. 2014 Dec;21(6):673-83
pubmed: 25267831
Nat Med. 2005 Jul;11(7):791-6
pubmed: 15951748
Nature. 2006 May 4;441(7089):101-5
pubmed: 16625202
J Virol. 2005 Mar;79(5):2689-99
pubmed: 15708988
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9294-9
pubmed: 15939869